Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 3, 2008, Pages 360-366

  Vinodkumar, C ^a   Kalsurmath, Suneeta ^a   Neelagund, Y ^b  

^a S S INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE   (India)

^b GULBARGA UNIVERSITY   (India)

Author keywords

Bacteriophage; Mice; Multidrug resistant; P. aeruginosa; Septicemia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CONTROLLED STUDY; LETHALITY; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE; SEPTICEMIA;

ANIMALS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; SEPSIS;

EID: 50149105283     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.42511     Document Type: Article

References (21)

1. Sharma M, Goel N, Chaudhary U, Aggarwal R, Arora DR. Bacteremia in children. Indian J Pediatr 2002;69:1029-32.
2. Arlet G, Sanson Le Rouveau G. Out break of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 B-lactamases. Eur J Clin Microbiol Infect Dis 1990;9:797-803.
3. Santosh K, Bhargava MD, Kishan J. Low birth weight and its sequelae: The Indian experience. Indian J Pediatr 1980;47:117-21.
4. Aggarwal R, Sarkar N, Ashok K, Deorari, Vinod K. Sepsis in the newborn. Indian J Pediatr 2001;68:1143-51.
5. Barrow PA. Novel approaches to control of bacterial infections in animals. Acta Vet Hung 1997: 45:317-29.
6. Chopra I, Hodgbon J, Metcalf B, Porte G. New approaches to the control of infections caused by antibiotic-resistant bacteria: An industry perspective. J Am Med Assoc 1996;10:401-4.
7. Duckworth, Donna H, Gulig Paul A. Bacteriophages: Potential treatment for bacterial infections. Biodrug 2002;16:57-62.
8. Smith HW, Huggins MB. Successful treatment of experimental E. coli infections in mice using phage: Its superiority over antibiotics. J Gen Microbiol 1982;128:307-18.
9. Alisky JK, Rapoport, Troitsky. Bacteriophage shows promise as antimicrobial agents. J Infect 1998;36:5-15.
10. Bauer AW, Kirby WM, Sherris JC, Jurek M. Antibiotic susceptibility testing by a standardized disc method. Am J Clin Pathol 1966;45:493-6.
11. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 2002;70:204-10.
12. Tartero C, Araujo R, Michel T, Jofe J. Culture and methods affecting decontaminating, enumeration of phage infecting Bacteriodes fragilis in sewage. Appl Envir Microbiol 1992;58:2670-3.
13. nd ed. New York: Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 1989.
14. Bojovazova GG, Voroshilova NN, Bondarenko VM. The efficacy of Klebsiella bacteriophage in the therapy of experimental Klebsiella infection. J Microbiol Epidemiol Immunobiol 1991;4:5-8.
15. Gowri SR, Madhusudhan V, Palaniappan P. Evaluation of phage therapy to treat experimental infection in mice. Indian J Microbiol 1998;38:101-3.
16. Soothill JS. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 1994;20:209-11.
17. Eaton MD, Stanhope BJ. Bacteriophage therapy. JAMA 1934;103:1769-76.
18. Bush K. New beta lactamases in Gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001;32:1085-9.
19. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, et al. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: An alternative therapy for treatment of bacterial infections. Antimicrob Agents Chemother 2003;47:1301-7.
20. Dubos RJ, Straus JH, Pierce C. The multiplication of bacteriophage in-vivo and its protective effect against an experimental infection with Shigella dysenteriae. J Exp Med 1943; 20:191-8.
21. Barrow P, lovell M, Berchieri A. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol 1998;5:294-8.